Posted on 8/06/2022
Rob joined Rayner in November 2021. Rob has spent 18 years working in the finance industry and ophthalmology clinical practice.
Rob spent over a decade advising healthcare companies on strategic and financial matters. He was previously at William Blair where he was the Head of Medtech in Europe. Prior to William Blair, Rob was a member of the Global Healthcare M&A teams at Perella Weinberg Partners, Nomura and commenced his banking career at Lehman Brothers. He holds a medical and science degree from Imperial College and trained as an ophthalmic surgeon practising in the UK.
Rob is a keen tennis player and between matches likes spending time with his young children.